AstraZeneca K.K. and United Immunity have signed an agreement for joint research on next-generation lipid nanoparticles ...
Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised ...
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop FG-M701, a ...
Oncocross, a Seoul-based artificial intelligence (AI) drug discovery and development biotech startup, has signed a joint...
Japan-based Shionogi & Co. and Maze Therapeutics, Inc., in the US, have completed an exclusive worldwide license agr...
A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII) has deve...
invoX Pharma, a UK-based research-driven global biopharmaceutical company with an advancing pipeline of innovative produ...
Japanese Foundation for Cancer Research (JFCR) and Takeda Pharmaceutical have signed a partnership agreement with the go...
Takeda Pharmaceutical, Astellas Pharma and Sumitomo Mitsui Banking Corporation (SMBC), in Japan, have signed a master ag...
German firm Boehringer Ingelheim and Japan-based Sosei Group Corporation have entered a global collaboration and exclusi...
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...
Taiwan-based BioGate Precision Medicine Corp., a member of Powerchip Group, has unveiled an innovative breakthrough in p...
UK-based University of Dundee’s Drug Discovery Unit has announced a renewed partnership with Japanese pharmaceut...
Chugai Pharmaceutical has decided to position its research subsidiary in Singapore, Chugai Pharmabody Research...
Nikon Instruments Inc. has announced the establishment of the Nikon BioImaging Lab Lexington in Massachusetts, US, ...
China-based startup Sanyou Biopharmaceuticals has officially announced the launch of its "Sanyou Super Trillion Pep...
Japan-based Ono Pharmaceutical has entered into a research collaboration agreement with UK Dementia Research Institute (...
Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...
